BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3028074)

  • 1. Pharmacological "enkephalinase" inhibition in man.
    Marcello F; Grazia SM; Sergio M; Federigo S
    Adv Exp Med Biol; 1986; 198 Pt B():153-60. PubMed ID: 3028074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF.
    Spillantini MG; Geppetti P; Fanciullacci M; Michelacci S; Lecomte JM; Sicuteri F
    Eur J Pharmacol; 1986 Jun; 125(1):147-50. PubMed ID: 3015640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of bestatin-sensitive aminopeptidase, angiotensin converting enzyme and thiorphan-sensitive "enkephalinase" in the potency of enkephalins in the guinea-pig ileum.
    Aoki K; Kajiwara M; Oka T
    Jpn J Pharmacol; 1984 Sep; 36(1):59-65. PubMed ID: 6094902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantiomers of [R,S]-thiorphan: dissociation of analgesia from enkephalinase A inhibition.
    Scott WL; Mendelsohn LG; Cohen ML; Evans DA; Frederickson RC
    Life Sci; 1985 Apr; 36(13):1307-13. PubMed ID: 2984500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
    Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; Fournié-Zaluski MC
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxone-insensitive potentiation of neurotensin hypothermic effect by the enkephalinase inhibitor thiorphan.
    Coquerel A; Dubuc I; Menard JF; Kitabgi P; Costentin J
    Brain Res; 1986 Nov; 398(2):386-9. PubMed ID: 3542125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inactivation of [Met5]-enkephalin by bestatin-sensitive aminopeptidase, captopril-sensitive peptidyl dipeptidase A and thiorphan-sensitive endopeptidase-24.11 in mouse vas deferens.
    Aoki K; Kajiwara M; Oka T
    Jpn J Pharmacol; 1986 Feb; 40(2):297-302. PubMed ID: 3009948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice.
    Roques BP; Fournié-Zaluski MC; Soroca E; Lecomte JM; Malfroy B; Llorens C; Schwartz JC
    Nature; 1980 Nov; 288(5788):286-8. PubMed ID: 7001254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1H NMR configurational correlation for retro-inverso dipeptides: application to the determination of the absolute configuration of "enkephalinase" inhibitors. Relationships between stereochemistry and enzyme recognition.
    Fournié-Zaluski MC; Lucas-Soroca E; Devin J; Roques BP
    J Med Chem; 1986 May; 29(5):751-7. PubMed ID: 3517331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition.
    Patey G; De La Baume S; Schwartz JC; Gros C; Roques B; Fournie-Zaluski MC; Soroca-Lucas E
    Science; 1981 Jun; 212(4499):1153-5. PubMed ID: 7015510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labelling and exploration of the active site of enkephalinase (EC 3.4.24.11) in kidney membranes with [3H]thiorphan as ligand.
    De la Baume S; Schwartz JC
    Eur J Pharmacol; 1988 Apr; 149(1-2):121-9. PubMed ID: 3165067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enkephalinase is involved in the degradation of endogenous substance P released from slices of rat substantia nigra.
    Mauborgne A; Bourgoin S; Benoliel JJ; Hirsch M; Berthier JL; Hamon M; Cesselin F
    J Pharmacol Exp Ther; 1987 Nov; 243(2):674-80. PubMed ID: 2445957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of the hypoglycemic effect of insulin by thiorphan, an enkephalinase inhibitor.
    Chipkin RE; Kreutner W; Billard W
    Eur J Pharmacol; 1984 Jun; 102(1):151-4. PubMed ID: 6383841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo.
    Mendelsohn LG; Johnson BG; Scott WL; Frederickson RC
    J Pharmacol Exp Ther; 1985 Aug; 234(2):386-90. PubMed ID: 3894620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enkephalinase inhibitors and molecular study of the differences between active sites of enkephalinase and angiotensin-converting enzyme].
    Roques BP
    J Pharmacol; 1985; 16 Suppl 1():5-31. PubMed ID: 2993752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enkephalinase inhibitor, GB 52, does not affect nociceptive flexion reflexes nor pain sensation in humans.
    Willer JC; Roby A; Ernst M
    Neuropharmacology; 1986 Aug; 25(8):819-22. PubMed ID: 3022176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo effects of thiorphan: an inhibitor of enkephalinase A.
    Chipkin RE; Iorio LC; Barnett A; Berger J; Billard W
    Adv Biochem Psychopharmacol; 1982; 33():235-42. PubMed ID: 6751031
    [No Abstract]   [Full Text] [Related]  

  • 18. Origin of the stimulation of food intake by oral administration of enkephalinase inhibitors in sheep.
    Rivière PJ; Buéno L
    Life Sci; 1987 Jul; 41(3):333-9. PubMed ID: 3298911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enkephalinase 'A' inhibition by thiorphan: central and peripheral cardiovascular effects.
    Baum T; Becker FT; Sybertz EJ; Sabin C; Desiderio DM
    Eur J Pharmacol; 1983 Oct; 94(1-2):85-91. PubMed ID: 6360696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enkephalinase inhibitor potentiates substance P- and electrically induced contraction in ferret trachea.
    Sekizawa K; Tamaoki J; Nadel JA; Borson DB
    J Appl Physiol (1985); 1987 Oct; 63(4):1401-5. PubMed ID: 2447055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.